Glycosylation and cancer: Moving glycomics to the forefront

Advances in Cancer Research

Volumn 126, Issue , 2015, Pages 1-10

  Drake, Richard R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Biomarker; Cancer; Glycoproteins; Glycosylation

Indexed keywords

MICRORNA; GLYCOPROTEIN; TUMOR PROTEIN;

ARTICLE; CANCER GROWTH; CANCER RESEARCH; CANCER TISSUE; ENZYME SPECIFICITY; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENE CONTROL; GENE MUTATION; GLYCOBIOLOGY; GLYCOSYLATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; METABOLISM; NEOPLASM; PATHOLOGY;

GLYCOMICS; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; NEOPLASM PROTEINS; NEOPLASMS;

EID: 84923307262     PISSN: 0065230X     EISSN: 21625557     Source Type: Book Series    
DOI: 10.1016/bs.acr.2014.12.002     Document Type: Chapter

References (39)

1. Abdel Rahman A.M., Ryczko M., Pawling J., Dennis J.W. Probing the hexosamine biosynthetic pathway in human tumor cells by multitargeted tandem mass spectrometry. ACS Chemical Biology 2013, 8(9):2053-2062.
2. Adamczyk B., Tharmalingam T., Rudd P.M. Glycans as cancer biomarkers. Biochimica et Biophysica Acta 2012, 1820(9):1347-1353.
3. Agrawal P., Kurcon T., Pilobello K.T., Rakus J.F., Koppolu S., Liu Z. Mapping posttranscriptional regulation of the human glycome uncovers microRNA defining the glycocode. Proceedings of the National Academy of Sciences of the United States of America 2014, 111(11):4338-4343.
4. Amano M., Yamaguchi M., Takegawa Y., Yamashita T., Terashima M., Furukawa J., et al. Threshold in stage-specific embryonic glycotypes uncovered by a full portrait of dynamic N-glycan expression during cell differentiation. Molecular & Cellular Proteomics 2010, 9(3):523-537.
5. Barton J.G., Bois J.P., Sarr M.G., Wood C.M., Qin R., Thomsen K.M., et al. Predictive and prognostic value of CA 19-9 in resected pancreatic adenocarcinoma. Journal of Gastrointestinal Surgery 2009, 13:2050-2058.
6. Bertozzi C.R., Kiessling L.L. Chemical glycobiology. Science 2001, 291(5512):2357-2364.
7. Clark G.F. The role of carbohydrate recognition during human sperm-egg binding. Human Reproduction 2013, 28(3):566-577.
8. Drake R.R., Jones E.E., Powers T.W., Nyalwidhe J.O. Altered glycosylation in prostate cancer. Advances in Cancer Research 2015, 126:345-382.
9. Drake R.R., Kislinger T. The proteomics of prostate cancer exosomes. Expert Reviews of Proteomics 2014, 11:167-177.
10. Elbein A.D. Glycosidase inhibitors: Inhibitors of N-linked oligosaccharide processing. The FASEB Journal 1991, 5(15):3055-3063.
11. Freire-de-Lima L. Sweet and sour: The impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition. Frontiers in Oncology 2014, 4:59.
12. Gloster T.M. Development of inhibitors as research tools for carbohydrate-processing enzymes. Biochemical Society Transactions 2012, 40(5):913-928.
13. Guo H., Abbott K. Functional impact of tumor-specific N-linked glycan changes in breast and ovarian cancers. Advances in Cancer Research 2015, 126:281-304.
14. Haltiwanger R.S., Lowe J.B. Role of glycosylation in development. Annual Review of Biochemistry 2004, 73:491-537.
15. Holst S., Wuhrer M., Rombouts Y. Glycosylation characteristics of colorectal cancer. Advances in Cancer Research 2015, 126:203-256.
16. Jones E.E., Dworski S., Canals D., Casas J., Fabrias G., Schoenling D., et al. On-tissue localization of ceramides and other sphingolipids by MALDI mass spectrometry imaging. Analytical Chemistry 2014, 86(16):8303-8311.
17. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. The Journal of Clinical Investigation 2009, 119(6):1420-1428.
18. Kamali A., Holodniy M. Influenza treatment and prophylaxis with neuraminidase inhibitors: A review. Infection and Drug Resistance 2013, 6:187-198.
19. Kasper B.T., Koppolu S., Mahal L.K. Insights into miRNA regulation of the human glycome. Biochemical and Biophysical Research Communications 2014, 445(4):774-779.
20. Kudelka M.R., Ju T., Heimburg-Molinaro J., Cummings R.D. Simple sugars to complex disease-Mucin-type O-glycans in cancer. Advances in Cancer Research 2015, 126:53-136.
21. Lemjabbar-Alaoui H., McKinney A., Yang Y., Tran V.M., Phillips J.J. Glycosylation alterations in lung and brain cancer. Advances in Cancer Research 2015, 126:305-344.
22. Leymarie N., Griffin P.J., Jonscher K., Kolarich D., Orlando R., McComb M. Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: The ABRF glycoprotein research multi-institutional study 2012. Molecular & Cellular Proteomics 2013, 12:2935-2951.
23. Liang Y., Eng W.S., Colquhoun D.R., Dinglasan R.R., Graham D.R., Mahal L.K. Complex N-linked glycans serve as a determinant for exosome/microvesicle cargo recruitment. The Journal of Biological Chemistry 2014, 289(47):32526-32537.
24. Ludwig J.A., Weinstein J.N. Biomarkers in cancer staging, prognosis and treatment selection. Nature Reviews. Cancer 2005, 5:845-860.
25. Mehta A., Herrera H., Block T. Glycosylation and liver cancer. Advances in Cancer Research 2015, 126:257-280.
26. Nagel A., Ball L.E. Intracellular protein O-GlcNAc modification integrates nutrient status with transcriptional regulation and glucose metabolism. Advances in Cancer Research 2015, 126:137-166.
27. Nairn A.V., Aoki K., dela Rosa M., Porterfield M., Lim J.M., Kulik M., et al. Regulation of glycan structures in murine embryonic stem cells: Combined transcript profiling of glycan-related genes and glycan structural analysis. The Journal of Biological Chemistry 2012, 287(45):37835-37856.
28. Nigam V.N., Cantero A. Polysaccharides in cancer. Advances in Cancer Research 1973, 16:1-96.
29. Nigam V.N., Cantero A. Polysaccharides in cancer: Glycoproteins and glycolipids. Advances in Cancer Research 1973, 17:1-80.
30. Nyalwidhe J.O., Betesh L.R., Powers T.W., Jones E.E., White K.Y., Burch T.C., et al. Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression. Proteomics. Clinical Applications 2013, 7:677-689.
31. Powers T.W., Jones E.E., Betesh L.R., Romano P.R., Gao P., Copeland J.A., et al. Matrix assisted laser desorption ionization imaging mass spectrometry workflow for spatial profiling analysis of N-linked glycan expression in tissues. Analytical Chemistry 2013, 85:9799-9806.
32. Powers T.W., Neely B.A., Shao Y., Tang H., Troyer D.A., Mehta A.S., et al. MALDI imaging mass spectrometry profiling of N-glycans in formalin-fixed paraffin embedded clinical tissue blocks and tissue microarrays. PLoS One 2014, 9(9):e106255.
33. Ramani V.C., Purushothaman A., Stewart M.D., Thompson C.A., Vlodavsky I., Au J.L., et al. The heparanase/syndecan-1 axis in cancer: Mechanisms and therapies. The FEBS Journal 2013, 280(10):2294-2306.
34. Simpson M.A., Heldin P. Hyaluronan signaling and turnover. Advances in Cancer Research 2014, 123:1-385.
35. Tang H., Hsueh P., Kletter D., Bern M., Haab B. The detection and discovery of glycan motifs in biological samples using lectins and antibodies: New methods and opportunities. Advances in Cancer Research 2015, 126:167-202.
36. Taniguchi N., Kizuka Y. Glycans and cancer: Role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics. Advances in Cancer Research 2015, 126:11-52.
37. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
38. Varki A., Cummings R., Esko J., Freeze H., Stanley P., Bertozzi C.R., et al. Essentials of glycobiology 2009, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 2nd ed.
39. Winzler R.J. Plasma proteins in cancer. Advances in Cancer Research 1953, 1:503-548.